controversial

FDA panel backs highly controversial ALS drug in rare 2nd review

FDA panel backs highly controversial ALS drug in rare 2nd review

WASHINGTON (AP) — A panel of federal health advisers voted Wednesday to recommend approval of an experimental drug to treat Lou Gehrig’s disease, a remarkable turnaround for the highly controversial drug which was previously rejected by the same group earlier this year. Food and Drug Administration advisers voted 7 to 2 that Amylyx Pharma’s data …

FDA panel backs highly controversial ALS drug in rare 2nd review Read More »

FDA advisers recommend approval of controversial ALS drug

FDA advisers recommend approval of controversial ALS drug

Independent advisers to the Food and Drug Administration voted 7-2 on Wednesday to recommend approval of an experimental ALS drug with strong support from patients and advocates, making it likely the highly controversial treatment will be approved by the agency in a few weeks. The vote was a stunning reversal from late March when the …

FDA advisers recommend approval of controversial ALS drug Read More »